Thiogamma 600 has the main ingredient is thioctic acid, film-coated tablet dosage form. Compliance with indications and doses of Thiogamma 600 will help patients improve treatment effectiveness and avoid unwanted side effects.

Diabetes mellitus (DM) is considered the leading cause of end-stage renal disease requiring renal replacement therapy. Diabetic nephropathy, also known as diabetic kidney disease, belongs to the group of microvascular complications of diabetes, and is one of the leading causes of chronic kidney disease and end-stage renal failure in the world.